EUVIMEDEUVIMED entdecken
Crossref

Bifidobacterium animalis subspecies lactis HN019 can reduce the sequelae of experimental periodontitis in rats modulating intestinal parameters, expression of lipogenic genes, and levels of hepatic steatosis

André L G Moreira, Giselle A Silva, Pedro H F Silva iD, Sérgio L Salvador iD, Raphael M Vicente, Graziele C Ferreira, Jose E Tanus-Santos, Marcia P A Mayer iD, Karin H Ishikawa iD, Sérgio Luís Scombatti de Souza, Flávia A C Furlaneto, Michel R Messora iD

Journal of Periodontal Research · 2023

DOI: 10.1111/jre.13163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Periodontal Research, 2023. Verfasst von André L G Moreira und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery and Periodontology, School of Dentistry of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto…. Hauptthemen laut MEDLINE: Bifidobacterium animalis, Insulin Resistance, Probiotics, Periodontitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 110 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine whether Bifidobacterium animalis subspecies lactis HN019 ( B. lactis HN019) can reduce the sequelae of experimental periodontitis (EP) in rats modulating systemic parameters.

Background

This study evaluated the effects of probiotic therapy (PROB) in the prevention of local and systemic damage resulting from EP.

Methods

Forty‐eight rats were allocated into four groups: C (control), PROB, EP, and EP‐PROB. PROB (1 × 10 10 CFU/mL) administration lasted 8 weeks and PE was induced on the 7th week by placing ligature on the animals' lower first molars. All animals were euthanized in the 9th week of the experiment. Biomolecular analyses, RT‐PCR, and histomorphometric analyses were performed. The data obtained were analyzed statistically (ANOVA, Tukey, p < .05).

Results

The EP group had higher dyslipidemia when compared to the C group, as well as higher levels of insulin resistance, proteinuria levels, percentages of systolic blood pressure, percentage of fatty hepatocytes in the liver, and expression of adipokines was up‐regulated (LEPR, NAMPT, and FABP4). All these parameters (except insulin resistance, systolic blood pressure, LEPR and FABP4 gene expression) were reduced in the EP‐PROB group when compared to the EP group. The EP group had lower villus height and crypt depth, as well as a greater reduction in Bacteroidetes and a greater increase in Firmicutes when compared to the EP‐PROB group. Greater alveolar bone loss was observed in the EP group when compared to the EP‐PROB group.

Conclusion

Bifidobacterium lactis HN019 can reduce the sequelae of EP in rats modulating intestinal parameters, attenuating expression of lipogenic genes and hepatic steatosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bifidobacterium animalisInsulin ResistanceProbioticsPeriodontitisFatty LiverRatsAnimalsIntestinal Mucosa

Stichwörter der Autor:innen

Bifidobacterium lactisperiodontitisprobiotics

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery and Periodontology, School of Dentistry of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil.
  • Department of Clinical Analyses, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil.
  • Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil.
  • Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

ORCID-Profile: Pedro H F Silva, Sérgio L Salvador, Marcia P A Mayer, Karin H Ishikawa, Michel R Messora

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Moreira, A. L. G., Silva, G. A., Silva, P. H. F., Salvador, S. L., Vicente, R. M., Ferreira, G. C., Tanus-Santos, J. E., Mayer, M. P. A., Ishikawa, K. H., de Souza, S. L. S., Furlaneto, F. A. C., & Messora, M. R. (2023). Bifidobacterium animalis subspecies lactis HN019 can reduce the sequelae of experimental periodontitis in rats modulating intestinal parameters, expression of lipogenic genes, and levels of hepatic steatosis. Journal of Periodontal Research. https://doi.org/10.1111/jre.13163

Vancouver

Moreira ALG, Silva GA, Silva PHF, Salvador SL, Vicente RM, Ferreira GC, et al. Bifidobacterium animalis subspecies lactis HN019 can reduce the sequelae of experimental periodontitis in rats modulating intestinal parameters, expression of lipogenic genes, and levels of hepatic steatosis. Journal of Periodontal Research. 2023. doi:10.1111/jre.13163

BibTeX
@article{Moreira2023,
  author = {Moreira, André L G and Silva, Giselle A and Silva, Pedro H F and Salvador, Sérgio L and Vicente, Raphael M and Ferreira, Graziele C and Tanus-Santos, Jose E and Mayer, Marcia P A and Ishikawa, Karin H and de Souza, Sérgio Luís Scombatti and Furlaneto, Flávia A C and Messora, Michel R},
  title = {Bifidobacterium animalis subspecies lactis HN019 can reduce the sequelae of experimental periodontitis in rats modulating intestinal parameters, expression of lipogenic genes, and levels of hepatic steatosis},
  journal = {Journal of Periodontal Research},
  year = {2023},
  doi = {10.1111/jre.13163}
}
Kostenlos starten →